Halozyme Therapeutics, Inc. (HALO) financial statements (2020 and earlier)

Company profile

Business Address 11388 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121-1345
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12035546920510813672
Cash and cash equivalents1205816967436127
Short-term investments 297300138657444
Receivables593022163299
Inventory, net of allowances, customer advances and progress billings2923515966
Inventory2923515966
Prepaid expense308210111
Other undisclosed current assets3041212122097
Total current assets:54342851025717216195
Noncurrent Assets
Property, plant and equipment11744433
Restricted cash and investments1111111
Other undisclosed noncurrent assets11460613
Total noncurrent assets:22121051057
TOTAL ASSETS:566440520262182166102
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities62544832312325
Accounts payable6484433
Accrued liabilities56504029271415
Employee-related liabilities     67
Debt2092771722  
Restructuring reserve     1
Deferred revenue and credits475977
Other undisclosed current liabilities4    (6)(7)
Total current liabilities:8614913155622425
Noncurrent Liabilities
Long-term debt and lease obligation383    5050
Long-term debt, excluding current maturities383    5050
Liabilities, other than long-term debt575540485147
Deferred revenue and credits55440444747
Deferred revenue1
Deferred tax liabilities, net    00
Other liabilities4210430
Total noncurrent liabilities:388755404810096
Total liabilities:47415618695111125122
Stockholders' equity
Stockholders' equity attributable to parent92249208(32)4341(20)
Common stock0000000
Additional paid in capital695780731553526492362
Accumulated other comprehensive income (loss)0(0)(0)(0)(0)(0)0
Accumulated deficit(604)(531)(522)(585)(483)(450)(382)
Total stockholders' equity:92249208(32)4341(20)
Other undisclosed liabilities and equity 3512519928(0)(0)
TOTAL LIABILITIES AND EQUITY:566440520262182166102

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1961523171471357555
Revenue, net1523171471357555
Cost of revenue
(Cost of Goods and Services Sold)
(46)(10)(31)(33)(29)(23)(6)
Gross profit:1501422851131065349
Operating expenses(218)(211)(204)(197)(133)(117)(129)
Other undisclosed operating income     20
Operating income (loss):(68)(69)81(83)(27)(63)(80)
Nonoperating income7831000
Investment income, nonoperating   1000
Other nonoperating income783    
Interest and debt expense(12)(18)(22)(20)(5)(6)(3)
Income (loss) from continuing operations before equity method investments, income taxes:(73)(80)62(102)(32)(68)(83)
Other undisclosed income from continuing operations before income taxes00     
Income (loss) from continuing operations before income taxes:(72)(80)62(102)(32)(68)(83)
Income tax expense (benefit)0(1)1(1)   
Net income (loss) available to common stockholders, diluted:(72)(80)63(103)(32)(68)(83)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(72)(80)63(103)(32)(68)(83)
Other comprehensive income (loss)0(0)(0)0(0)(0)0
Comprehensive income (loss):(72)(80)63(103)(32)(68)(83)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent10(0)    
Comprehensive income (loss), net of tax, attributable to parent:(72)(80)63(103)(32)(68)(83)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: